Timeline
AstraZeneca and Ionis ATTR-CM trial fails primary endpoint
OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design
Physiomics wins contracts across two service lines
Segro doubles new rent secured in first half as development pipeline hits record
Coiled Therapeutics advances softgel formulation ahead of dose expansion
MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic
The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika
PureTech spins out Celea Therapeutics with $180m Raise
Supermarket Income REIT completes £445m debt refinancing at lower margin
ECO Animal Health launches poultry vaccine ECOVAXXIN MS across EU
Physiomics promotes Head of Biometrics to Chief Operating Officer
Health & Bio Today: Oxford BioDynamics appoints new CEO and lands US partnership, Futura Medical, Poolbeg Pharma, Rua Life Sciences
SSE's transmission unit eyes £12bn grid update investment pipeline
Poolbeg Pharma wins South Africa patent for POLB 001 to 2038
Futura Medical WSD4000 studies show superiority ahead of pivotal trial
Health & Bio Today: Creo Medical lifts FY26 guidance after Q1 beat, Verici Dx, Futura Medical, genedrive, AstraZeneca
AstraZeneca's Datroway wins EU approval recommendation for first-line triple-negative breast cancer
Health & Bio Today: Physiomics flags record pipeline after boardroom overhaul, Crism Therapeutics, Panther Securities, Beximco Pharmaceuticals
Crism Therapeutics shares rose after FDA Orphan Drug Designation
Physiomics flags record commercial pipeline after boardroom overhaul
Beximco Pharma posts 11% revenue rise as export sales surge 38%
Cavendish reiterates 'buy' on HUTCHMED with 436p target after 19% share-price slide
ImmuPharma names Bachem as manufacturing partner for Kapiglucagon drug program
Hutchmed's fanregratinib hits 42.5% response rate in bile duct cancer trial
FDA clears single pivotal trial path for Avacta's AVA6000 in salivary gland cancer
Health & Bio Today: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Primary Health Properties, Verici Dx, Beximco Pharmaceuticals, Cambridge Cognition
Beximco Pharma half-year profit surges 36% as domestic and export sales both accelerate
Thalia Therapeutics acquires AML RNA therapy company in deal backed by £2.75m raise
Primary Health Properties in advanced talks to form private hospital portfolio joint venture
Deutsche Bank holds GSK at 1,900p as prescription tracker flags mixed product trends
Beximco Pharma delivers first doses of generic cystic fibrosis treatment at 96% discount to US price
Avacta starts dosing patients in AVA6103 trial with cash runway extended to early 2027
Solvonis Therapeutics hits key PK milestone for esketamine AUD programme
Proteome Sciences wins chemoproteomics contract ahead of new clinical trial
Ondine Biomedical expects Phase 3 top-line results within three weeks
ValiRx ends University of Dundee drug discovery collaboration after technology fails to meet licensing threshold
Health & Bio Today: Genedrive gains NHS traction in Manchester, Ondine Biomedical, Regional REIT
Regional REIT secures £1.1m rent on two vacant Nottingham offices
Ondine Biomedical nasal photodisinfection cuts brain surgery infections by 78.5%
tinyBuild sales beat expectations in first five months as pipeline builds
Coiled Therapeutics adds two oncology specialists to Medical Advisory Board
The Premarket Brief: PZ Cussons upgrades profit guidance, Smiths News wins £125m News UK deal, Social Housing REIT, AO World
Social Housing REIT agrees £108.3m purchase of ReSI senior living portfolio
Health & Bio Today: BSF Enterprise, Cizzle Biotechnology, Poolbeg Pharma, Istesso, Inspiration Healthcare
Poolbeg Pharma granted European patent for POLB 001 in CRS
Istesso starts Phase 2 trial of leramistat in sarcopenia
Health & Bio Today: AstraZeneca's Truqap wins FDA approval for prostate cancer
Fusion Antibodies wins InnovateUK grant to humanise DR5 antibody
The Premarket Brief: Reabold in takeover talks with Union Jack Oil, Frasers Group's Aussie bid, Peel Hunt, AstraZeneca
More in Healthcare
Genedrive's personalised medicine receives Parliament boost
A government minister named Genedrive's newborn hearing-loss test as a live example of personalised medicine during a House of Commons committee session.